MedTrace Logo

REFLECTION: A Clinical Practice Learning Program for Galleri®

NCT05205967 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 14633

Last updated 2025-11-26

No results posted yet for this study

Summary

REFLECTION is a multi-center, prospective, non-interventional, cohort study that will enroll approximately 14,000 individuals who have opted to be screened with Galleri®, a blood-based, multi-cancer early detection (MCED) test in routine clinical settings. The purpose of the study is to understand the real-world experience of Galleri® in clinical settings.

Conditions

  • Early Detection of Cancer
  • Cancer

Interventions

OTHER

MCED

Multi-cancer early detection (MCED) test

OTHER

SOC

Standard of care cancer screening

Sponsors & Collaborators

  • GRAIL, Inc.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-23
Primary Completion
2025-09-30
Completion
2026-10-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05205967 on ClinicalTrials.gov